The recent withdrawal of Hims & Hers’ GLP-1 pill raises questions about the safety and effectiveness of compounded medications ...

Make sure the clinician knows what other medications you’re taking, and set up a real follow-up plan to adjust these medications and your GLP-1 dose, she added. Also, seek ongoing guidance on diet and ...

DMT clinical trials are producing rapid, sustained depression relief in as little as twenty minutes — and forcing researchers ...

The FDA said on Friday it plans to restrict GLP-1 ingredients used in non-approved compounded drugs from companies like Hims & Hers.

Here, researchers from Hassan II University of Casablanca in Morocco found that a compound called beta sitosterol, produced in aloe vera leaves, may be helpful in tackling Alzheimer's, too.

Indiana lawmakers are weighing new guardrails around drug compounding amid warnings that patients are receiving powerful prescription treatments in settings that operate largely outside state ...

After years of wide-open compounding, regulators say they’re ready to enforce limits and restore control over the fast-growing GLP-1 market.

Novo Nordisk is asking the court to permanently ban Hims from selling compounded versions of its drugs that infringe on the company's patents, and is seeking to recover damages. The move escalates the ...

Tirzepatide (Zepbound, Mounjaro) is a dual-agonist GLP-1 medication. It works like a GLP-1 agonist, but also targets a ...

From antibiotic resistance to emerging viral threats, the global demand for new medicines is intensifying, yet traditional drug discovery pipelines remain slow and expensive. A new scientific review ...